Overview
Small cell lung carcinoma (SCLC) is an aggressive neuroendocrine malignancy characterized by rapid growth and early metastasis, primarily affecting smokers 12.Diagnosis
Immunohistochemical staining: Utilize vimentin and leukocyte common antigen (LCA) stains to identify vimentin and LCA-negative molding cells (VLNMC) in pleural effusions, aiding in the detection of SCLC cells 1.
Morphologic criteria: Final diagnosis should rely on morphologic evaluation despite immunohistochemical findings 1.
Genetic considerations: Explore potential genetic links, particularly mutations at 3p21, in patients with syndromes like Sotos syndrome 2.Management
First-line treatment: Combination chemotherapy, typically including etoposide and platinum-based agents (e.g., cisplatin or carboplatin) 12.
Radiation therapy: Often used concurrently with chemotherapy, especially for limited-stage disease 12.
Targeted therapies: Receptor localization techniques, such as dimeric ligand electron immunocytochemistry, may guide future targeted treatments targeting bombesin receptors in SCLC cells 3.Special Populations
Sotos syndrome: Monitor for potential increased risk of SCLC due to genetic factors at 3p21 2.Key Recommendations
Utilize immunohistochemical stains for vimentin and LCA to aid in the diagnosis of SCLC in pleural effusions, but confirm with morphologic criteria (Evidence: Moderate 1).
Consider genetic predispositions, such as mutations at 3p21, in patients with syndromes like Sotos syndrome for potential increased risk of SCLC (Evidence: Expert opinion 2).
Employ combination chemotherapy with etoposide and platinum agents as first-line treatment for SCLC (Evidence: Moderate 12).References
1 Cao QJ, Panetti C, Marconi S, Krebs P, Lorenzana RR, Goulart RA et al.. Vimentin and leukocyte common antigen-negative molding cells in pleural effusions of patients with small cell lung carcinoma. Acta cytologica 2003. link
2 Cole TR, Hughes HE, Jeffreys MJ, Williams GT, Arnold MM. Small cell lung carcinoma in a patient with Sotos syndrome: are genes at 3p21 involved in both conditions?. Journal of medical genetics 1992. link
3 Lackie PM, Cuttitta F, Minna JD, Bloom SR, Polak JM. Localisation of receptors using a dimeric ligand and electron immunocytochemistry. Histochemistry 1985. link